Get the Stockscreener App
15.30
5.56%
-0.90
After Hours:
15.30
Surgery Partners Inc stock is traded at $15.30, with a volume of 1.20M.
It is down -5.56% in the last 24 hours and down -3.59% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$16.20
Open:
$16.11
24h Volume:
1.20M
Relative Volume:
0.65
Market Cap:
$1.98B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-56.67
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-2.11%
1M Performance:
-3.59%
6M Performance:
-28.03%
1Y Performance:
-28.00%
1-Day Range:
$15.22
$16.15
1-Week Range:
$15.22
$16.28
52-Week Range:
$14.94
$26.16
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
15.30 | 2.10B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
505.84 | 107.79B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
189.15 | 16.69B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.42 | 12.86B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
202.64 | 12.88B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
171.99 | 10.32B | 4.11B | 239.98M | 193.10M | 4.12 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Aug Intraday: Is Surgery Partners Inc affected by consumer sentimentQuarterly Profit Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Price-Driven Insight from (SGRY) for Rule-Based Strategy - Stock Traders Daily
Quarterly Recap: What is Surgery Partners Incs 5 year growth outlookJuly 2025 Snapshot & Fast Gain Swing Alerts - baoquankhu1.vn
Surgery Partners stock jumps on takeover bid - MSN
Is Surgery Partners Inc the Silent Healthcare Cheat Code Wall Street Slept On? - AD HOC NEWS
Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Surgery Partners prices $425M senior notes offering - MSN
Restore Orthopaedic Surgical Institute surged into the top 10 knee replacement providers in the Philly area - MSN
(SGRY) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Aug Closing: Can Surgery Partners Inc grow without dilutionPortfolio Return Report & Capital Efficiency Focused Ideas - baoquankhu1.vn
Deals tracker: Hospital Sisters Health, Lifepoint Health partner - Modern Healthcare
Total debt per share of Surgery Partners, Inc. – FWB:1SP - TradingView — Track All Markets
How The Story Behind Surgery Partners (SGRY) Is Shifting As Analysts Reset Expectations - Yahoo Finance
Bond Watch: How supply chain issues affect Surgery Partners Inc. stockJuly 2025 Catalysts & High Conviction Buy Zone Picks - Bộ Nội Vụ
Barclays Maintains Surgery Partners (SGRY) Equal-Weight Recommendation - MSN
RBC Capital and Mizuho Securities Stay Bullish on Surgery Partners (SGRY) - Finviz
Surgery partners' chief HR officer sells $4,288 in stock - MSN
SGRY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Surgery Partners, Inc. Shareholders Who Lost Money - ACCESS Newswire
Tangible book value per share of Surgery Partners, Inc. – DUS:1SP - TradingView — Track All Markets
Can Surgery Partners Inc. stock maintain growth trajectoryDividend Stock Watch & Beat the Market With Predictive Algorithms - Улправда
Sivik Global Healthcare LLC Purchases 95,000 Shares of Surgery Partners, Inc. $SGRY - MarketBeat
Should I hold or sell Surgery Partners Inc. stock in 20252025 Performance Recap & Free Community Consensus Stock Picks - ulpravda.ru
Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 65.94% Upside Potential Amid Sector Growth - DirectorsTalk Interviews
ATTENTION Surgery Partners, Inc. (SGRY) Investors: Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
COMPASS SURGICAL PARTNERS NAMES MARK LANGSTON CHIEF EXECUTIVE OFFICER - Yahoo Finance
Surgery Partners, Inc. $SGRY Stake Lessened by Voya Investment Management LLC - MarketBeat
Surgery Partners beats Q2 expectations, reaffirms 2025 guidance - MSN
Surgery Partners Inc (SGRY) Is Quietly Exploding – Are You Sleeping On This Stock? - AD HOC NEWS
Portfolio Update: Is Surgery Partners Inc stock cheap at current valuationJuly 2025 Gainers & AI Powered Market Entry Strategies - moha.gov.vn
Surgery Partners' takeover offer should rekindle interestanalyst - MSN
Bain Capital proposes to buy out Surgery Partners at $25.75 per share - MSN
Surgery Partners, Inc.Common Stock (NQ: SGRY - FinancialContent
Cash Machine Trading CheapSurgery Partners Stock Set to Run? - Trefis
Surgery Partners subsidiary prices $425M add-on notes - MSN
Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring the 61.62% Potential Upside for Investors - DirectorsTalk Interviews
Surgery Partners Earnings Notes - Trefis
Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Mizuho Securities Reaffirm Bullish Stance on Surgery Partners (SGRY) - Finviz
Squarepoint Ops LLC Cuts Stock Position in Surgery Partners, Inc. $SGRY - MarketBeat
RBC Capital Keeps Their Buy Rating on Surgery Partners (SGRY) - The Globe and Mail
How strong is Surgery Partners Inc. stock balance sheet2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
How supply chain issues affect Surgery Partners Inc. stockJuly 2025 Outlook & Verified Swing Trading Watchlists - Улправда
Will Surgery Partners Inc. stock benefit from green energy trendsDollar Strength & Free Daily Entry Point Trade Alerts - DonanımHaber
Can Surgery Partners Inc. stock continue upward trendWeekly Trend Report & Low Risk Growth Stock Ideas - Улправда
Surgery Partners (SGRY): Reassessing Valuation After Guidance Cut, Legal Probe, and Analyst Target Reductions - Sahm
Total debt per share of Surgery Partners, Inc. – BER:1SP - TradingView — Track All Markets
Targets Report: How supply chain issues affect Surgery Partners Inc. stockJuly 2025 Chart Watch & Reliable Breakout Forecasts - ulpravda.ru
Surgery Partners (SGRY) Analyst Ratings Update: Price Target Low - GuruFocus
Surgery Partners (NASDAQ:SGRY) Price Target Cut to $19.00 by Analysts at Mizuho - MarketBeat
Surgery Partners (SGRY) Is Down 10.9% After $425M Debt Raise And Baylor PartnershipWhat's Changed - simplywall.st
Healthcare Stocks Analysis 2025: Sell Surgery Partners, Watch ResMedNews and Statistics - IndexBox
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):